Bayesian Capital Management, LP Day One Biopharmaceuticals, Inc. Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
A detailed history of Bayesian Capital Management, LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 28,100 shares of DAWN stock, worth $197,824. This represents 0.03% of its overall portfolio holdings.
Number of Shares
28,100
Previous 18,000
56.11%
Holding current value
$197,824
Previous $142,000
28.17%
% of portfolio
0.03%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
182Shares Held
69.2MCall Options Held
122KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$45.3 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$43.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$31.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$28.8 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$26.2 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $517M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...